Skip to main content
Caplight Logo









Iconeus

Iconeus

Private
ParisHealthcare & Life Scienceshttps://iconeus.com/

Last Round

Grant

Apr 11, 2022

Total Funding Raised

$1.28M

Company Overview

Iconeus is a biotechnology company that develops functional ultrasound (fUS) neuroimaging solutions for preclinical neuroscience research and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Biotech Equipment, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

functional ultrasound imagingfUSneuroscience researchneurovascular imagingbrain activity mappingmedical imaging hardwarepreclinical imagingneuroimagingdrug discoverybiotech equipmentneurovascular couplinganimal modelslab techin vivo imagingresearch tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Iconeus Comparables

Compare Iconeus with similar companies based on industry and business-model similarity.

Iconeus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fujifilm Holdings Corporation
77%
S-Sharp Corporation
77%
MR Solutions
76%

Iconeus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 11, 2022
GrantJan 22, 2020

Key People

Founding team and executive leadership

Ludovic Lecointre

CEO & Co-founder

Founding Team

Irma Tanon

Chief Financial Officer

Executive Team

Iconeus Investors

Notable investors and investment history

Iconeus investors
InvestorRounds
AgoranovAccelerator
European Innovation Council FundGrant
Paris Biotech SantéAccelerator
European Commission (Horizon Europe)Grant
PC'up IncubatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors increased 49% MoM.

  • May 10, 2025

    Grew 15% QoQ, from 33 to 38 employees.

Iconeus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Iconeus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Iconeus's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range40
Year Founded2016
Last FundingApr 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?